Amy Hancock
Medical · Myrtle Beach, SCNPI 1346350089
Payments from drug & device makers
Across 77 payments — averaging $27.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$585
- Si-bone, Inc.$392
- Collegium Pharmaceutical, Inc.$281
- Forte Bio-pharma LLC$163
- Vertos Medical, Inc.$113
- Medtronic$110
- plus $468 from 13 others
What the payments were for
- Food & beverage$2,112100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 15 | $585 |
| Si-bone, Inc. | 9 | $392 |
| Collegium Pharmaceutical, Inc. | 17 | $281 |
| Forte Bio-pharma LLC | 8 | $163 |
| Vertos Medical, Inc. | 2 | $113 |
| Medtronic | 4 | $110 |
| AbbVie | 3 | $96 |
| Vertex | 3 | $71 |
| Scilex Pharmaceuticals Inc. | 3 | $62 |
| GRT US Holding, Inc. | 2 | $40 |
| Curonix LLC | 2 | $35 |
| Biodelivery Sciences International, Inc. | 2 | $30 |
| Tonix Medicines, Inc. | 1 | $27 |
| Nalu Medical, Inc. | 1 | $22 |
| Protega Pharmaceutials Inc | 1 | $21 |
| Nevro Corp. | 1 | $19 |
| Spinal Simplicity, LLC | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,112 in reported general payments places this provider in the 65th percentile of 384 medical providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 109 | $66,017 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,042 | $23,338 |
| BotoxOnabotulinumtoxina | 14 | $16,850 |
| OxycontinOxycodone Hcl | 34 | $12,941 |
| LinzessLinaclotide | 18 | $9,791 |
| Morphine Sulfate ErMorphine Sulfate | 430 | $9,712 |
| Hysingla ErHydrocodone Bitartrate | 15 | $9,535 |
| ButransBuprenorphine | 12 | $6,159 |
| Gabapentin | 341 | $3,712 |
| Naloxone Hcl | 42 | $2,538 |
| Cyclobenzaprine Hcl | 241 | $1,590 |
| Pregabalin | 54 | $1,476 |
| Lidocaine | 12 | $1,096 |
| Tramadol Hcl | 96 | $954 |
| Trazodone Hcl | 65 | $722 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $281 | $66,017109 claims |
| AbbVieBotox, Linzess | $96 | $26,64232 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 384 medical providers in South Carolina.
Other medical in Myrtle Beach
- Lindsay JohnsonMyrtle Beach$11K
- Bleselda ParagasMyrtle Beach$8K
- Tanya BralleyMyrtle Beach$7K
- Sanford HardinMyrtle Beach$5K
- Christopher ThompsonSpartanburg$78K
- Laura BuchGreenville$73K
- Suzanne SmithWest Columbia$39K
- Stavros ChrysostomidesColumbia$39K
- Ethan CaseySpartanburg$24K
- Jessica HallColumbia$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.